- ►annals.org [PDF] Z Levi, P Rozen, R Hazazi, A Vilkin, A Waked, … - Annals of internal medicine, 2007 - Am Coll Physicians Background: Guaiac-based fecal occult blood tests (FOBTs) for colorectal cancer
screening are not specific for human hemoglobin and have low sensitivity.
Automated-development, immunochemi- cal FOBT is quality-controlled, is ... Cited by 70 - Related articles - BL Direct - All 3 versions
- ►oxfordjournals.org JE Allison, LC Sakoda, TR Levin, JP Tucker, … - JNCI Journal of the National Cancer Institute, 2007 - jnci.oxfordjournals.org Methods: We assessed prospectively the performance characteristics of two newer
FOBTs in 5841 subjects at average risk for colorectal cancer in a large
group–model managed care organization. The tests evaluated included a ... Cited by 48 - Related articles - BL Direct - All 8 versions
A Smith, GP Young, SR Cole, P Bampton - CA A Cancer Journal for Clinicians - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 51 - Related articles - BL Direct - All 6 versions
L Guittet, V Bouvier, N Mariotte, JP Vallee, D … - British Medical Journal, 2007 - gut.bmj.com Results: Using the usual cut-off point of 20 ng/ml haemoglobin, the gain in
sensitivity associated with the use of I-FOBT (50% increase for cancer and 256%
increase for high risk adenoma) was balanced by a decrease in specificity. ... Cited by 60 - Related articles - BL Direct - All 4 versions
T Morikawa, J Kato, Y Yamaji, R Wada, T … - Gastroenterology, 2005 - Elsevier Background & Aims: The fecal occult blood test (FOBT) is recommended as a
screening test for colorectal cancer, but there are few reliable studies on the
accuracy of immunochemical FOBT. The aim of this study was to analyze the ... Cited by 144 - Related articles - All 16 versions
A Vilkin, P Rozen, Z Levi, A Waked, E Maoz, S … - American Journal of Gastroenterology, 2005 - interscience.wiley.com OBJECTIVES: Guaiac fecal occult blood colorectal cancer (CRC) screening tests
(FOBT) are faulted for low sensitivity and nonspecificity for human hemoglobin
(Hb). Automated-developed, immunochemical, human Hb FOBT (I-FOBT) is ... Cited by 42 - Related articles - BL Direct - All 6 versions
SH Itzkowitz, L Jandorf, R Brand, L Rabeneck … - Clinical Gastroenterology and Hepatology, 2007 - Elsevier Background & Aims: Fecal DNA testing has shown greater sensitivity than
guaiac-based occult blood tests for noninvasive colorectal cancer (CRC)
screening. The prototype assay (version 1), which analyzed 22 gene ... Cited by 76 - Related articles - All 15 versions
BCY Wong, WM Wong, KL Cheung, TSM Tong, … - Alimentary Pharmacology and Therapeutics, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 40 - Related articles - BL Direct - All 5 versions
PD Greenberg, L Bertario, R Gnauck, O … - The American journal of gastroenterology, 2000 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 74 - Related articles - BL Direct - All 6 versions
GD Launoy, HJ Bertrand, C Berchi, VY … - International journal of cancer, 2005 - interscience.wiley.com Colorectal cancer screening is a high public health priority in all
industrialized countries. However, the low sensitivity of the common guaiac
screening test (HemoccultII) makes practitioners and public health decision ... Cited by 39 - Related articles - All 3 versions
